Volcano Corp buys medical imaging solutions developer for $17.3 mln

By Admin
US medical devices company Volcano Corporation has acquired medical imaging solutions developer Sync-Rx Ltd for $17.3 million. Sync-Rx is jointly owned...

US medical devices company Volcano Corporation has acquired medical imaging solutions developer Sync-Rx Ltd for $17.3 million. Sync-Rx is jointly owned by Rafael Advanced Defense Systems Ltd and Elron Electronic Industries Ltd, through its joint venture Rafael Development Corporation.

It develops automated online image processing to optimize and facilitate trans-catheter cardiovascular interventions.

The acquisition will be closed within 30 days. Sync-Rx was founded in 2007 and it will become the wholly owned subsidiary of San Diego-based Volcano.

It currently focuses on coronary catheterizations and it plans to develop applications for structural heart disease. The company also plans to expand Sync-Rx’s technology to work with real-time intra-body physiology measurements and intravascular ultrasound, intra-cardiac echocardiography, and optical coherence tomography imaging. 

Volcano President and CEO Scott Huennekens said, “Sync-Rx’s technology provides Volcano with a platform on which to build a range of advanced software features that will help in clinical decision-making by providing co-registration capabilities and future opportunities in physiology and peripheral and minimally invasive structural heart therapy guidance.” Mr. Scott also said, “We are excited about the Sync-Rx team joining Volcano and establishing a footprint in Israel, given the breadth and depth of medical imaging and software talent there.”

Ian Biran, Chairman, Rafael and Sync-Rx said, “ Sync-Rx’s platform is another example of state-of-the-art technology developed in Israel that has demonstrated global superiority. For RDC, this is another success story which follows the successes of Given Imaging Ltd and Medingo, which grew at RDC achieved breakthroughs and became leaders in their fields.”

 Volcano Corporation develops, manufactures and commercializes vast range of devices.

Share
Share

Featured Articles

Google DeepMind's AlphaFold 3 'is Drug Discovery Boost'

Google DeepMind's AlphaFold 3 is an AI model that can predict the structures and interactions of molecules and will help scientists unlock new medicines

UnitedHealth CEO Admits Hack hit Third of US Citizens' Data

UnitedHealth Group CEO Andrew Witty tells stunned US congressional hearing Change Healthcare cyberattack affects third of the US population

Why Sanofi Leads the way on Healthcare Sustainability

How French multinational Sanofi is ensuring delivery of essential medical supplies while being ESG-compliant

Philips Q1 Results hit by $1.1bn Respironics Settlement

Medical Devices & Pharma

Vaccine Breakthrough on Antibiotics Resistant Diseases

Medical Devices & Pharma

Oracle Fusion Cloud Update Boost for Patients

Technology & AI